Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review
Description
Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Vivimed Labs Ltd (Vivimed) specializes in developing and manufacturing generic and branded generic formulations, offering products in tablets, capsules, syrups, liquids, nasal sprays, and ointments. The company also provides contract manufacturing services to leading pharmaceutical firms. Vivimed, through its wholly owned subsidiary Uquifa, supplies active pharmaceutical ingredients (APIs) and intermediates to the global pharmaceutical industry. The company's contract manufacturing organization (CMO) division serves both domestic and international markets, including India and Canada. It operates certified manufacturing facilities in Uttarakhand and Telangana and has a dedicated R&D center in Telangana. Vivimed is headquartered in Hyderabad, Telangana, India.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Opportunities thaented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Vivimed Labs Ltd (Vivimed) specializes in developing and manufacturing generic and branded generic formulations, offering products in tablets, capsules, syrups, liquids, nasal sprays, and ointments. The company also provides contract manufacturing services to leading pharmaceutical firms. Vivimed, through its wholly owned subsidiary Uquifa, supplies active pharmaceutical ingredients (APIs) and intermediates to the global pharmaceutical industry. The company's contract manufacturing organization (CMO) division serves both domestic and international markets, including India and Canada. It operates certified manufacturing facilities in Uttarakhand and Telangana and has a dedicated R&D center in Telangana. Vivimed is headquartered in Hyderabad, Telangana, India.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Opportunities thaented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
37 Pages
- Section 1 - About the Company
- Vivimed Labs Ltd - Key Facts
- Vivimed Labs Ltd - Key Employees
- Vivimed Labs Ltd - Major Products and Services
- Vivimed Labs Ltd - History
- Vivimed Labs Ltd - Company Statement
- Vivimed Labs Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Vivimed Labs Ltd - Business Description
- Business Segment: Pharma
- Performance
- Business Segment: Speciality Chemicals
- Performance
- R&D Overview
- Vivimed Labs Ltd - Corporate Strategy
- Vivimed Labs Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Vivimed Labs Ltd - Strengths
- Vivimed Labs Ltd - Weaknesses
- Vivimed Labs Ltd - Opportunities
- Vivimed Labs Ltd - Threats
- Vivimed Labs Ltd - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Vivimed Labs Ltd, Recent Deals Summary
- Section 5 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Vivimed Labs Ltd, Key Facts
- Vivimed Labs Ltd, Key Employees
- Vivimed Labs Ltd, Major Products and Services
- Vivimed Labs Ltd, History
- Vivimed Labs Ltd, Other Locations
- Vivimed Labs Ltd, Subsidiaries
- Vivimed Labs Ltd, Joint Venture
- Vivimed Labs Ltd, Key Competitors
- Vivimed Labs Ltd, Ratios based on current share price
- Vivimed Labs Ltd, Annual Ratios
- Vivimed Labs Ltd, Annual Ratios (Cont...1)
- Vivimed Labs Ltd, Annual Ratios (Cont...2)
- Vivimed Labs Ltd, Interim Ratios
- Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Vivimed Labs Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Vivimed Labs Ltd, Performance Chart (2021 - 2025)
- Vivimed Labs Ltd, Ratio Charts
- Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
